Volume 5 Supplement 8

22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies

Open Access

Daphnane diterpene hirsein B downregulates melanogenesis in B16 murine melanoma cells by cAMP pathway inhibition

BMC Proceedings20115(Suppl 8):P68

DOI: 10.1186/1753-6561-5-S8-P68

Published: 22 November 2011

Background

Skin pigmentation serves as protection against ultraviolet-induced skin damage through melanin’s optical and chemical filtering properties [1]. Although melanin plays and important role in skin protection, excessive melanin production or hyperpigmentation may lead to skin cancer. Recently, the inhibition of melanogenesis has been considered as a valid therapeutic target for the management of advanced melanotic melanomas [2] which increases the need for melanogenesis inhibitors that are of plant origin and are not cytotoxic to mammalian cells. The biosynthesis of the pigment melanin is catalyzed by the melanogenic enzymes tyrosinase, tyrosinase related protein 1 and the dopachrome tautomerase, the transcriptional regulation of which is being regulated by the microphthalmia associated transcription factor (Mitf) [3]. Previously, we have reported that hirsein B (HB) or 5β-hydroxyresiniferonol-6α,7α-epoxy-12β-coumaroyloxy-9,13,14-ortho-decanoate from Thymelaea hirsuta [4] has antimelanogenesis effect (without cytotoxicity) on B16 murine melanoma cells by downregulating the expressions of the Mitf gene and the melanogenic enzymes’ genes [5]. The exact mechanism by which hirsein B inhibited the Mitf gene expression, however, has not yet been determined. In melanogenesis, the Mitf gene expression can be regulated through the cAMP pathway or the Wnt signaling pathway. This study aimed to determine the mechanism underlying the inhibitory effect of HB on Mitf gene in B16 murine melanoma cells.

Materials and methods

Total RNA was isolated from B16 murine melanoma cells (Riken Cell Bank, Tsukuba, Japan) and used for DNA microarray analysis, using chips of 528 spots loaded with 265 genes prepared by Genopal™ (Mitsubishi Rayon Co., Ltd, Tokyo, Japan), to determine the expressions of genes for melanogenesis, membrane-bound receptors, tyrosine kinase regulation, melanosome transport, and other cell signal regulation-related genes (including the housekeeping and negative control genes). To validate the results, real-time PCR, using TaqMan FAST 7500 (Applied Biosystems, Foster City, CA, USA) and specific TaqMan primers (Applied Biosystems, Foster City, CA, USA) for the differentially-expressed genes, was performed.

Results

Results showed that the expressions of the Mitf gene and the melanogenic enzymes’ genes were downregulated, verifying our previous report [5]. In addition, the expression of the gene for melanocortin 1 receptor (Mc1r) of the cAMP pathway was downregulated while most of the genes that were upregulated are those involved in the Wnt signaling pathway (Table 1).
Table 1

Differentially-expressed genes in hirsein B-treated B16 murine melanoma cells as determined by DNA microarray.

Biological Process

Differentially expressed genes

Up- or Down- regulated

Melanin biosynthesis

Mitf, Mc1r

Downregulated

Melanosome transport

Rab27a, Mlph, Myo5A, Myo7A

Downregulated

Negative regulation of transcription from RNA polymerase II promoter

Sorbs3

Downregulated

Wnt signaling pathway

Ppap2b, Wisp, Kremen1

Upregulated

Cell cycle regulation

Gadd45b, Csnkl

Upregulated

Activation of MAPK signaling pathway

Gadd45b , Pxn, Map2k3, Met, Avpi1, Spag9

Upregulated

Cytoskeleton organization

Pxn

Upregulated

Protein phosphorylation

Mapkapk3

Upregulated

In mouse, peptide hormones from the pituitary gland bind to the MC1R and stimulate melanin production through the cAMP/PKA signalling pathway [6], by inducing changes in the protein phosphorylation and gene expression, through the MITF gene product.

Conclusions

The results obtained suggest that the significant antimelanogenesis effect of hirsein B is through the inhibition of the expression of the Mc1r gene of the cAMP pathway. HB may therefore be used as a treatment for hyperpigmentation due to its significant melanogenesis downregulation effects in B16 cells or as a pretreatment for melanotic melanomas.

Declarations

Acknowledgment

This study was partially supported by the Science and Technology Research Partnership for Sustainable Development (SATREPS).

Authors’ Affiliations

(1)
Graduate School of Life and Environmental Sciences, University of Tsukuba
(2)
Alliance for Research on North Africa (ARENA), University of Tsukuba
(3)
Yokohama Corporate Research Laboratories, Mitsubishi Rayon Co., Ltd

References

  1. Ahene AB, Saxena S, Nacht S: Photoprotection of solubilized and microdispersed melanin particles. Melanin, Its Role in Human Photoprotection. Edited by: Zeise L, Chedekel M, Fitzpatrick TB. 1995, Overland Park, KS: Valendmar, 255-269.Google Scholar
  2. Slominski A, Zbytek B, Slominski R: Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer. 2009, 124: 1470-1477. 10.1002/ijc.24005.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Slominski A, Tobin DJ, Shibahara S, Wortsman J: Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004, 84: 1155-1228. 10.1152/physrev.00044.2003.View ArticlePubMedGoogle Scholar
  4. Miyamae Y, Orlina-Villareal M, Isoda H, Shigemori H: Hirseins A and B, daphnane diterpenoids from Thymelaea hirsuta that inhibit melanogenesis in B16 melanoma cells. J Nat Prod. 2009, 72: 938-941. 10.1021/np800808h.View ArticlePubMedGoogle Scholar
  5. Villareal M, Han J, Yamada P, Shigemori H, Isoda H: Hirseins inhibit melanogenesis by regulating the gene expressions of Mitf and melanogenesis enzymes. Exp Dermatol. 2010, 19: 617-627. 10.1111/j.1600-0625.2009.01053.x.View ArticleGoogle Scholar
  6. Busca R, Ballotti R: Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 2000, 13: 60-69. 10.1034/j.1600-0749.2000.130203.x.View ArticlePubMedGoogle Scholar

Copyright

© Villareal et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement